PAA 0.00% 17.5¢ pharmaust limited

Company presenting at Techknow in Sydney (today)/ Melbourne (tomorrow), page-67

  1. 1,066 Posts.
    lightbulb Created with Sketch. 2158
    Zolvix Plus does not cross the blood brain barrier due to the water based mixture with Abermectin.

    NZT you are correct mostly.

    If seperated by chromatography the Monepantel will then cross the BBB.

    Only a person with considerable knowledge would be able to do it. Like me.

    Taking the Zolvix combination long term could cause central nervous system issues. Abermectin is also used as a fire ant bait.
    In sheep etc it is not an issue due to the frequency of drenching.

    Does anyone know if Monepantel crosses into the substantia nigata. I have asked five learned people so far and no answer. I will persist and ask more. My gut feeling is yes.

    I am looking way ahead, at off label usage for combination therapy once FDA approves Monepantel and then for Multiple Systems Atrophy MSA. Another insidious disease similar to full blown MND cases.

    MSA is caused by iron in the neurons in the substantia nigata. Certain drugs can rid the iron but it leaves a protein aggregation similar to MND that causes continual dysfunction.

    Monepantel as the "garbage" collection drug will help them and MND. My studied thoughts.

    Monepantel one day in the future my friends.

    Kpax






 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
17.5¢
Change
0.000(0.00%)
Mkt cap ! $85.12M
Open High Low Value Volume
18.0¢ 18.0¢ 17.0¢ $141.2K 801.7K

Buyers (Bids)

No. Vol. Price($)
11 537419 17.0¢
 

Sellers (Offers)

Price($) Vol. No.
18.0¢ 140000 3
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.